TD-4208
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Revefenacin (TD‐4208) is a novel, long‐acting, and lung‐selective muscarinic cholinergic receptor (mAChR) antagonist in…
ABSTRACT Introduction: Long acting muscarinic receptor antagonists (LAMA) reverse airflow obstruction by antagonizing para…
Introduction TD-4208 is a lung-selective, LAMA shown to have a long duration of action and minimal systemic antimuscarinic…
Tiotropium is currently the only once-daily, long-acting muscarinic antagonist (LAMA) approved in the United States and other…
Background: TD-4208 is a potent and selective inhaled muscarinic antagonist with functional lung selectivity and long duration in…